Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Alzheimer Disease D000544 76 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Body Weight D001835 333 associated lipids
Cleft Lip D002971 8 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Proteostasis Deficiencies D057165 5 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
Mehrotra A and Sandhir R Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation. 2014 Behav. Brain Res. pmid:24393741
Farahpour MR and Ghayour SJ Effect of in situ delivery of acetyl-L-carnitine on peripheral nerve regeneration and functional recovery in transected sciatic nerve in rat. 2014 Int J Surg pmid:25448663
Lindeboom L et al. Long-echo time MR spectroscopy for skeletal muscle acetylcarnitine detection. 2014 J. Clin. Invest. pmid:25271624
Dodd MS et al. Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy. 2014 Circ Cardiovasc Imaging pmid:25201905
Callander N et al. Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. 2014 Cancer Chemother. Pharmacol. pmid:25168296
Bigford GE and Del Rossi G Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders. 2014 Adv Nutr pmid:25022989
Li S and Laher I Exercise Pills: At the Starting Line. 2015 Trends Pharmacol. Sci. pmid:26439443
Sarkar S et al. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine. 2015 Neurosci. Lett. pmid:26321151
Lindsay KL et al. Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy. 2015 PLoS ONE pmid:26716698
Robinson BL et al. Opposing effects of ketamine and acetyl L-carnitine on the serotonergic system of zebrafish. 2015 Neurosci. Lett. pmid:26365406

Table of Content